272 related articles for article (PubMed ID: 22997207)
1. Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population.
Lange P; Marott JL; Vestbo J; Olsen KR; Ingebrigtsen TS; Dahl M; Nordestgaard BG
Am J Respir Crit Care Med; 2012 Nov; 186(10):975-81. PubMed ID: 22997207
[TBL] [Abstract][Full Text] [Related]
2. Comparison of global initiative for chronic obstructive pulmonary disease 2013 classification and body mass index, airflow obstruction, dyspnea, and exacerbations index in predicting mortality and exacerbations in elderly adults with chronic obstructive pulmonary disease.
Chen CZ; Ou CY; Yu CH; Yang SC; Chang HY; Hsiue TR
J Am Geriatr Soc; 2015 Feb; 63(2):244-50. PubMed ID: 25641518
[TBL] [Abstract][Full Text] [Related]
3. GOLD classifications and mortality in chronic obstructive pulmonary disease: the HUNT Study, Norway.
Leivseth L; Brumpton BM; Nilsen TI; Mai XM; Johnsen R; Langhammer A
Thorax; 2013 Oct; 68(10):914-21. PubMed ID: 23611880
[TBL] [Abstract][Full Text] [Related]
4. [The importance of the at risk COPD patients (Stage 0) and clinical differences].
Kömüs N; Tertemiz KC; Sevinç C
Tuberk Toraks; 2008; 56(4):382-9. PubMed ID: 19123073
[TBL] [Abstract][Full Text] [Related]
5. The importance of cardiovascular disease for mortality in patients with COPD: a prognostic cohort study.
Zhang J; Rutten FH; Cramer MJ; Lammers JW; Zuithoff NP; Hoes AW
Fam Pract; 2011 Oct; 28(5):474-81. PubMed ID: 21602286
[TBL] [Abstract][Full Text] [Related]
6. Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD.
Bridevaux PO; Gerbase MW; Probst-Hensch NM; Schindler C; Gaspoz JM; Rochat T
Thorax; 2008 Sep; 63(9):768-74. PubMed ID: 18505800
[TBL] [Abstract][Full Text] [Related]
7. Validation of the GOLD 2013 classification in predicting exacerbations and mortality in Taiwanese patients with chronic obstructive pulmonary disease.
Chen CZ; Ou CY; Hsu CH; Hsiue TR
J Formos Med Assoc; 2015 Dec; 114(12):1258-66. PubMed ID: 25676673
[TBL] [Abstract][Full Text] [Related]
8. [GOLD 2011 - COPD from a new perspective].
Rubinsztajn R; Przybyłowski T; Maskey-Warzechowska M; Karwat K; Chazan R
Pol Merkur Lekarski; 2013 Apr; 34(202):192-5. PubMed ID: 23745323
[TBL] [Abstract][Full Text] [Related]
9. Surgical treatment for lung cancer with COPD based on the Global Initiative for Chronic Obstructive Lung Disease (GOLD).
Iwasaki A; Shirakusa T; Enatsu S; Maekawa S; Yoshida Y; Yoshinaga Y
Thorac Cardiovasc Surg; 2005 Jun; 53(3):162-7. PubMed ID: 15926096
[TBL] [Abstract][Full Text] [Related]
10. Inspiratory capacity and forced expiratory volume in the first second in exacerbation of chronic obstructive pulmonary disease.
Yetkin O; Gunen H
Clin Respir J; 2008 Jan; 2(1):36-40. PubMed ID: 20298302
[TBL] [Abstract][Full Text] [Related]
11. Using post-bronchodilator FEV₁ is better than pre-bronchodilator FEV₁ in evaluation of COPD severity.
Chen CZ; Ou CY; Wang WL; Lee CH; Lin CC; Chang HY; Hsiue TR
COPD; 2012 Jun; 9(3):276-80. PubMed ID: 22360379
[TBL] [Abstract][Full Text] [Related]
12. Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes.
Garcia-Aymerich J; Gómez FP; Benet M; Farrero E; Basagaña X; Gayete À; Paré C; Freixa X; Ferrer J; Ferrer A; Roca J; Gáldiz JB; Sauleda J; Monsó E; Gea J; Barberà JA; Agustí À; Antó JM;
Thorax; 2011 May; 66(5):430-7. PubMed ID: 21177668
[TBL] [Abstract][Full Text] [Related]
13. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease.
Soler-Cataluña JJ; Martínez-García MA; Román Sánchez P; Salcedo E; Navarro M; Ochando R
Thorax; 2005 Nov; 60(11):925-31. PubMed ID: 16055622
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease.
Ofir D; Laveneziana P; Webb KA; Lam YM; O'Donnell DE
Am J Respir Crit Care Med; 2008 Mar; 177(6):622-9. PubMed ID: 18006885
[TBL] [Abstract][Full Text] [Related]
15. Impact of chronic obstructive pulmonary disease severity on surgical outcomes in patients undergoing non-emergent coronary artery bypass grafting.
Saleh HZ; Mohan K; Shaw M; Al-Rawi O; Elsayed H; Walshaw M; Chalmers JA; Fabri BM
Eur J Cardiothorac Surg; 2012 Jul; 42(1):108-13; discussion 113. PubMed ID: 22290913
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of chronic obstructive pulmonary disease in Uppsala, Sweden--the Burden of Obstructive Lung Disease (BOLD) study: cross-sectional population-based study.
Danielsson P; Ólafsdóttir IS; Benediktsdóttir B; Gíslason T; Janson C
Clin Respir J; 2012 Apr; 6(2):120-7. PubMed ID: 21651748
[TBL] [Abstract][Full Text] [Related]
17. Chronic obstructive pulmonary disease and body mass index in five Latin America cities: the PLATINO study.
Montes de Oca M; Tálamo C; Perez-Padilla R; Jardim JR; Muiño A; Lopez MV; Valdivia G; Pertuzé J; Moreno D; Halbert RJ; Menezes AM;
Respir Med; 2008 May; 102(5):642-50. PubMed ID: 18314321
[TBL] [Abstract][Full Text] [Related]
18. Comparison of 2011 and 2007 Global Initiative for Chronic Obstructive Lung Disease guidelines for predicting mortality and hospitalization.
Johannessen A; Nilsen RM; Storebø M; Gulsvik A; Eagan T; Bakke P
Am J Respir Crit Care Med; 2013 Jul; 188(1):51-9. PubMed ID: 23590268
[TBL] [Abstract][Full Text] [Related]
19. Classification of Chronic Obstructive Pulmonary Disease (COPD) according to the new Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017: Comparison with GOLD 2011.
Marçôa R; Rodrigues DM; Dias M; Ladeira I; Vaz AP; Lima R; Guimarães M
COPD; 2018 Feb; 15(1):21-26. PubMed ID: 29161163
[TBL] [Abstract][Full Text] [Related]
20. Severe exacerbations and BODE index: two independent risk factors for death in male COPD patients.
Soler-Cataluña JJ; Martínez-García MA; Sánchez LS; Tordera MP; Sánchez PR
Respir Med; 2009 May; 103(5):692-9. PubMed ID: 19131231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
